Ilika plc
("Ilika", the "Group", or the "Company")
AIM Rule 17 Schedule 2(g) Update
Ilika (AIM: IKA), an independent global expert in solid-state battery technology, announces the following update in relation to directors' disclosure for Keith Jackson, Non-Executive Chairman of the Company, pursuant AIM Rule 17 and Schedule 2(g) of the AIM Rules for Companies.
Libertine plc, a company of which Keith Jackson was a Non-Executive Chairman until 24 August 2024, was placed into administration on 27 August 2024.
For more information contact:
| Ilika plc | |
| Graeme Purdy, Chief Executive Jason Stewart, Chief Financial Officer | Via FTI Consulting |
| | |
| | |
| | |
| Panmure Liberum Limited (Nomad and Joint Broker) | Tel: 020 3100 2000 |
| Andrew Godber, John More | |
| Nikhil Varghese, Joshua Borlant | |
| | |
| | |
| Joh. Berenberg, Gossler & Co. KG (Joint Broker) | Tel: 020 3207 8700 |
| Matthew Armitt, Mark Whitmore, Detlir Elezi, | |
| Angus Murphy | |
| | |
| | |
| FTI Consulting (Comms Advisors) | ilika@fticonsulting.com |
| Ben Brewerton | |
| Elizabeth Adams | |
| Dwight Burden | |
About Ilika plc - https://www.ilika.com
Ilika specialises in the developing and commercialisation of solid-state batteries. The Company's mission is to rapidly develop leading-edge IP, manufacture and license solid state batteries for markets that cannot be addressed with conventional batteries due to their safety, charge rates, energy density and life limits. The Company achieves this by using ceramic-based lithium-ion technology that is inherently safe in manufacture and usage, higher thermal tolerance and easier to recycle which differentiates our products from existing batteries.
The Company has two product lines. Its Stereax batteries which are designed for powering miniature medical implants, industrial wireless sensors and specialist Internet of Things (IoT) applications and the Goliath large format batteries designed for EV cars and cordless appliances.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
